Competitive intelligence on
small-molecule drugs and
the 90,000 global patents
|Title:||Method for treating asthma using optically pure (R)-albuterol|
|Abstract:||The optically pure R(-) isomer of albuterol, which is substantially free of the S(+) isomer, is a potent bronchodilator for relieving the symptoms associated with asthma in individuals. A method is disclosed utilizing the optically pure R(-) isomer of albuterol for treating asthma while minimizing the side effects associated with chronic administration of racemic albuterol.|
|Inventor(s):||Barberich; Timothy J. (Concord, MA), Young; James W. (Still River, MA)|
|Assignee:||Sepracor, Inc. (Marlborough, MA)|
Patent Claim Types:|
see list of patent claims
|Country||Document Number||Publication Date|
|World Intellectual Property Organization (WIPO)||9109596||Jul 11, 1991|
|United States of America||5547994||Aug 20, 1996|
|United States of America||5760090||Jun 02, 1998|
|United States of America||5844002||Dec 01, 1998|
|United States of America||6083993||Jul 04, 2000|
|This preview shows a limited data set|
Subscribe for full access, or try a free trial
Export unavailable in trial.
Subscribe for complete access.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.